by maheshbhuva | May 22, 2024 | Uncategorized
Reinventing Reputation: One of Pharma’s Biggest Challenges One of the biggest challenges for the pharmaceutical industry is reinventing its reputation. This task requires converting public perception from negative or skeptical to positive and trustworthy. Key...
by maheshbhuva | May 22, 2024 | News Pharma
The production of medicines is crucial to the growth of Europe’s life science sector, driving demand for manufacturing space across the continent. While R&D is vital, delivering products to market requires adherence to Good Manufacturing Practice (GMP) guidelines....
by maheshbhuva | May 22, 2024 | News Pharma
The rise in pharmaceutical production is driving increased requirements for European Good Manufacturing Practice (GMP) facilities due to several key factors: 1. Increased Demand for Medications The global pharmaceutical market is expanding due to several trends: Aging...
by maheshbhuva | May 21, 2024 | Uncategorized
Sanofi and Regeneron’s Dupixent appears to be closing in on an FDA nod to expand its label to chronic obstructive pulmonary disorder (COPD). Data presented Monday at the American Thoracic Society (strengthen the company’s case for an approval....
by maheshbhuva | May 21, 2024 | News Pharma
The biologics market for inflammatory bowel disease is continually getting more competitive, and now Johnson & Johnson’s Tremfya is the latest medicine angling to make a mark in the space. As J&J awaits an FDA approval decision for Tremfya in ulcerative...
